Status:
UNKNOWN
Apolipoprotein D (ApoD) In Human Serum As Marker Of Parkinson's Disease
Lead Sponsor:
Privatklinik Villa Melitta
Conditions:
Parkinson's
Eligibility:
All Genders
20+ years
Brief Summary
In Italy affected people are 200,000 and every year Parkinson new cases are 10,000. Aging is the principle risk factor of Parkinson with the possibility of its development doubling every five years af...
Detailed Description
Total participants: n=180. Study Part 1: Health persons: n=90; Groups of health persons: n=3; Subjects per group: n=30. Study Part 2: Patients: n=90; Groups of patients: n=3; Subjects per group: n...
Eligibility Criteria
Inclusion
- Patients with Parkinson's disease in the pathological related stages (Hoehn and Yahr)
- Persons \> 20 years
Exclusion
- Patients with a neurodegenerative disorder different to Parkinson's disease
- Patients, who are post-ictus and/or traumatic brain injury (TBI)
- Patients, who are treated with antipsychotic drugs
- Obese persons (BMI \> 27)
- Idiopathic normal pressure idrocephalus (INPI)
- Paget's disease
- Breast cancer
- Adenocarcinoma of the prostate
- Glucose-6-phosphate (GSD-I) deficiency
- Insuline-resistance-related disorders
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01467960
Start Date
November 1 2011
End Date
November 1 2013
Last Update
October 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Privatklinik Villa Melitta
Bolzano, Südtirol, Italy, 39100